nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—attention deficit hyperactivity disorder	0.762	1	CbGaD
Cinitapride—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.011	0.286	CbGeAlD
Cinitapride—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00584	0.152	CbGeAlD
Cinitapride—HTR4—brain—attention deficit hyperactivity disorder	0.00518	0.135	CbGeAlD
Cinitapride—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00228	0.0595	CbGeAlD
Cinitapride—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00193	0.0503	CbGeAlD
Cinitapride—HTR2A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00156	0.0078	CbGpPWpGaD
Cinitapride—HTR1A—midbrain—attention deficit hyperactivity disorder	0.00151	0.0393	CbGeAlD
Cinitapride—HTR2A—forebrain—attention deficit hyperactivity disorder	0.00136	0.0354	CbGeAlD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00133	0.00665	CbGpPWpGaD
Cinitapride—HTR4—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00132	0.00659	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0013	0.00651	CbGpPWpGaD
Cinitapride—HTR1A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0013	0.00651	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00129	0.00647	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00125	0.00626	CbGpPWpGaD
Cinitapride—HTR1A—nervous system—attention deficit hyperactivity disorder	0.00124	0.0323	CbGeAlD
Cinitapride—HTR1A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00121	0.00605	CbGpPWpGaD
Cinitapride—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.00119	0.0311	CbGeAlD
Cinitapride—HTR1A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00117	0.00586	CbGpPWpGaD
Cinitapride—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.00117	0.0304	CbGeAlD
Cinitapride—HTR1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00115	0.00576	CbGpPWpGaD
Cinitapride—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00115	0.03	CbGeAlD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.0057	CbGpPWpGaD
Cinitapride—HTR1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00114	0.00569	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00112	0.00562	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00111	0.00558	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00109	0.00547	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00108	0.00541	CbGpPWpGaD
Cinitapride—HTR1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00106	0.0053	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00104	0.00523	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00102	0.00509	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00101	0.00506	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000994	0.00498	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000984	0.00493	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000982	0.00492	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000967	0.00484	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000955	0.00478	CbGpPWpGaD
Cinitapride—HTR1A—brain—attention deficit hyperactivity disorder	0.000947	0.0247	CbGeAlD
Cinitapride—HTR2A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000944	0.00473	CbGpPWpGaD
Cinitapride—HTR2A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000914	0.00458	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000902	0.00452	CbGpPWpGaD
Cinitapride—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000898	0.0234	CbGeAlD
Cinitapride—HTR1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00089	0.00446	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000878	0.00439	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000866	0.00434	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00085	0.00426	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000849	0.00425	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000835	0.00418	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000825	0.00413	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000788	0.00395	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000773	0.00387	CbGpPWpGaD
Cinitapride—HTR2A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000769	0.00385	CbGpPWpGaD
Cinitapride—HTR1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000741	0.00371	CbGpPWpGaD
Cinitapride—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000738	0.0192	CbGeAlD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000733	0.00367	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00073	0.00366	CbGpPWpGaD
Cinitapride—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000711	0.0185	CbGeAlD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00071	0.00355	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000698	0.00349	CbGpPWpGaD
Cinitapride—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000695	0.0181	CbGeAlD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000689	0.00345	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000679	0.0034	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000675	0.00338	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000663	0.00332	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000642	0.00321	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000628	0.00314	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000623	0.00312	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000608	0.00304	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000598	0.00299	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00059	0.00296	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000588	0.00295	CbGpPWpGaD
Cinitapride—HTR2A—brain—attention deficit hyperactivity disorder	0.000564	0.0147	CbGeAlD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00055	0.00275	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000514	0.00258	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00049	0.00245	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00048	0.0024	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000478	0.00239	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000463	0.00232	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000455	0.00228	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000455	0.00228	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00045	0.00225	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00045	0.00225	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.000449	0.00225	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000445	0.00223	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000436	0.00218	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.000436	0.00218	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000436	0.00218	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000423	0.00212	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000419	0.0021	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000414	0.00207	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000411	0.00206	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000392	0.00196	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000385	0.00193	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000377	0.00189	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000375	0.00188	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000365	0.00183	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000362	0.00181	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000358	0.00179	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000355	0.00178	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000355	0.00178	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000349	0.00175	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000349	0.00175	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000332	0.00166	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000324	0.00162	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000313	0.00157	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000309	0.00155	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000306	0.00153	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000306	0.00153	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000302	0.00151	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000301	0.00151	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000301	0.00151	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000293	0.00147	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000291	0.00146	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000287	0.00144	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.00138	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00027	0.00135	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00027	0.00135	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00027	0.00135	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000264	0.00132	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000263	0.00132	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000262	0.00131	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000262	0.00131	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000257	0.00129	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000257	0.00129	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000254	0.00127	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000253	0.00127	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000252	0.00126	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000251	0.00126	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000248	0.00124	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000246	0.00123	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000245	0.00123	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000243	0.00122	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000239	0.0012	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000238	0.00119	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000238	0.00119	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000237	0.00119	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000236	0.00118	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000234	0.00117	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000233	0.00117	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000233	0.00117	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000232	0.00116	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000231	0.00116	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000227	0.00114	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000226	0.00113	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000222	0.00111	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00022	0.0011	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000219	0.0011	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000219	0.0011	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000217	0.00109	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000215	0.00108	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000215	0.00108	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000214	0.00107	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000212	0.00106	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000211	0.00106	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000204	0.00102	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000201	0.00101	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000201	0.00101	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0002	0.001	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000195	0.000977	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000194	0.000969	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000192	0.00096	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00019	0.000953	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000189	0.000949	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000188	0.000941	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000187	0.000938	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000186	0.00093	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000182	0.000913	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000178	0.000893	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000176	0.000884	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000175	0.000876	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000173	0.000864	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000167	0.000837	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000166	0.00083	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000164	0.000823	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000164	0.00082	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000162	0.000813	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000162	0.00081	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000156	0.000781	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000156	0.00078	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000153	0.000764	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000152	0.000762	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000151	0.000757	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000151	0.000754	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000147	0.000738	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000145	0.000726	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000725	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000143	0.000716	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000143	0.000716	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000142	0.000709	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000141	0.000708	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00014	0.000703	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000139	0.000694	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.000691	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000136	0.000682	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000135	0.000674	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000133	0.000667	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000132	0.00066	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000131	0.000658	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000127	0.000638	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000127	0.000636	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000125	0.000627	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000125	0.000624	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000124	0.000619	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000123	0.000614	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000122	0.000612	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00012	0.0006	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000115	0.000577	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000113	0.000568	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000108	0.000539	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000106	0.00053	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	9.79e-05	0.00049	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	9.73e-05	0.000487	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	9.61e-05	0.000481	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	9.33e-05	0.000467	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	9.25e-05	0.000463	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	9.14e-05	0.000458	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.89e-05	0.000445	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	8.6e-05	0.000431	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.41e-05	0.000421	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.4e-05	0.000421	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.36e-05	0.000419	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.33e-05	0.000417	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	8.3e-05	0.000416	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.19e-05	0.00041	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.19e-05	0.00041	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.08e-05	0.000405	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.03e-05	0.000402	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.99e-05	0.0004	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	7.81e-05	0.000391	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.56e-05	0.000379	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.53e-05	0.000377	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.43e-05	0.000372	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.43e-05	0.000372	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.34e-05	0.000368	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	7.26e-05	0.000363	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.22e-05	0.000362	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.19e-05	0.00036	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.08e-05	0.000354	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.07e-05	0.000354	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.98e-05	0.00035	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.94e-05	0.000347	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.84e-05	0.000342	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.75e-05	0.000338	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.53e-05	0.000327	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.51e-05	0.000326	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.42e-05	0.000322	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.34e-05	0.000318	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.91e-05	0.000296	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.68e-05	0.000284	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.27e-05	0.000264	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.96e-05	0.000248	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.9e-05	0.000246	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.79e-05	0.00024	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.71e-05	0.000236	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.61e-05	0.000231	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.47e-05	0.000224	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.39e-05	0.00022	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.34e-05	0.000217	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.29e-05	0.000215	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.04e-05	0.000202	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.99e-05	0.0002	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.86e-05	0.000193	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.79e-05	0.00019	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.75e-05	0.000188	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.49e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.83e-05	0.000142	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.5e-05	7.51e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.3e-05	6.49e-05	CbGpPWpGaD
